Equities

Grand Pharmaceutical Group Ltd

Grand Pharmaceutical Group Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,4742,4832,866
Total Receivables, Net2,3242,2072,149
Total Inventory1,3891,3401,117
Prepaid expenses------
Other current assets, total829857646
Total current assets7,0166,8876,779
Property, plant & equipment, net3,9863,9423,802
Goodwill, net589644597
Intangibles, net1,6571,3981,010
Long term investments8,3988,4478,380
Note receivable - long term----0
Other long term assets------
Total assets22,51522,37121,057
LIABILITIES
Accounts payable1,330873734
Accrued expenses1,4991,6152,137
Notes payable/short-term debt19257.16
Current portion long-term debt/capital leases2,3533,2532,122
Other current liabilities, total530689565
Total current liabilities5,7316,4555,566
Total long term debt1,0521,2221,523
Total debt3,4234,5003,653
Deferred income tax222220198
Minority interest1136850
Other liabilities, total240265327
Total liabilities7,3588,2317,664
SHAREHOLDERS EQUITY
Common stock353535
Additional paid-in capital6,5236,5236,523
Retained earnings (accumulated deficit)9,6078,2246,535
Treasury stock - common(269)(187)(144)
Unrealized gain (loss)(279)(99)3.05
Other equity, total(460)(355)440
Total equity15,15814,14013,393
Total liabilities & shareholders' equity22,51522,37121,057
Total common shares outstanding3,5023,5193,550
Treasury shares - common primary issue48300
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.